Last reviewed · How we verify

NCT03677882

A Brief Mind-Body Bridging Intervention for Suicidal Ideation

Terminated NA Last updated 13 February 2024
What this trial tests

NA trial testing Mind Body Bridging Group Session in Suicidal Ideation in 13 participants. Terminated before completion.

Timeline
18 December 2018
Primary endpoint
31 January 2023
31 January 2023

Quick facts

Lead sponsorVA Salt Lake City Health Care System
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment13
Start date18 December 2018
Primary completion31 January 2023
Estimated completion31 January 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Salt Lake City Health Care System

Who can join

Adults 18 to 80, any sex, with Suicidal Ideation or Mind Body Bridging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine whether a Brief Mind-Body Bridging Intervention for Suicidal Ideation (MBB-SI) will result in short or longer-term reduction of psychological factors associated with suicidal ideation (SI) and/or suicide-related behaviors (SRB's) compared to Treatment as Usual (TAU).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Suicidal Ideation

Currently open trials in the same condition.

Other VA Salt Lake City Health Care System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03677882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing